The MiningNewsWire Podcast

Customer relationship management (“CRM”) is a process in which a business or organization uses data analysis to better understand massive amounts of information to determine the best strategies for interacting with current and potential customers. Evolving from rudimentary surveys in the 1970s used by a handful of companies, CRM has become the biggest software market in the world used by 91% of companies that have more than 11 employees. The market is dynamic and constantly evolving in order to maximize return on investment for companies around the world, with companies such as Infobird Co. Ltd (NASDAQ: IFBD) (Profile) growing rapidly as a name brand in China. Majors such as Alibaba Group Holding Limited (NYSE: BABA) are also part of the market getting in front of emerging trends, as are Zendesk Inc. (NYSE: ZEN), Twilio Inc. (NYSE: TWLO) and Salesforce.com Inc. (NYSE: CRM) by providing the critical software and know-how for companies to improve customer relationships, quickly engage new customers and drive higher sales.

Customer relationship management (“CRM”) is a process in which a business or organization uses data analysis to better understand massive amounts of information to determine the best strategies for interacting with current and potential customers. Evolving from rudimentary surveys in the 1970s used by a handful of companies, CRM has become the biggest software market in the world used by 91% of companies that have more than 11 employees. The market is dynamic and constantly evolving in order to maximize return on investment for companies around the world, with companies such as Infobird Co. Ltd (NASDAQ: IFBD) (Profile) growing rapidly as a name brand in China. Majors such as Alibaba Group Holding Limited (NYSE: BABA) are also part of the market getting in front of emerging trends, as are Zendesk Inc. (NYSE: ZEN), Twilio Inc. (NYSE: TWLO) and Salesforce.com Inc. (NYSE: CRM) by providing the critical software and know-how for companies to improve customer relationships, quickly engage new customers and drive higher sales.

An old investing proverb states “the trend if your friend.” Tested and proven through time, the proverb rarely does an investor wrong. To that point, two emerging trends that should be commanding attention are plant-based foods and food delivery. Both were disrupted during the COVID-19 pandemic but in slightly different ways as consumers became more in tune with their bodies while having to cope with shuttered restaurants amid global lockdowns and social-distancing mandates. With the coronavirus slowly slipping into the rear mirror, these markets should continue their upward treks undergirded by consumers adopting healthier, more convenient lifestyles. At the intersection of plant-based foods and food delivery is PlantX Life Inc. (CSE: VEGA) (Frankfurt: WNT1) (OTCQB: PLTXF) (Profile), a company on a mission to not just be a brand but also a lifestyle, partner to all brands, and the digital face of the entire plant-based community. Others looking to capitalize on the trend away from animal-based foods include Beyond Meat Inc. (NASDAQ: BYND), Tattooed Chef Inc. (NASDAQ: TTCF), Amazon.com Inc. (NASDAQ: AMZN) and Oatly Group AB (NASDAQ: OTLY).

An old investing proverb states “the trend if your friend.” Tested and proven through time, the proverb rarely does an investor wrong. To that point, two emerging trends that should be commanding attention are plant-based foods and food delivery. Both were disrupted during the COVID-19 pandemic but in slightly different ways as consumers became more in tune with their bodies while having to cope with shuttered restaurants amid global lockdowns and social-distancing mandates. With the coronavirus slowly slipping into the rear mirror, these markets should continue their upward treks undergirded by consumers adopting healthier, more convenient lifestyles. At the intersection of plant-based foods and food delivery is PlantX Life Inc. (CSE: VEGA) (Frankfurt: WNT1) (OTCQB: PLTXF) (Profile), a company on a mission to not just be a brand but also a lifestyle, partner to all brands, and the digital face of the entire plant-based community. Others looking to capitalize on the trend away from animal-based foods include Beyond Meat Inc. (NASDAQ: BYND), Tattooed Chef Inc. (NASDAQ: TTCF), Amazon.com Inc. (NASDAQ: AMZN) and Oatly Group AB (NASDAQ: OTLY).

The concept of “big data” has been around for decades but only took on its current form in the 21st century with computers running 24/7/365 processing mounds of user data to better understand and predict trends. However, consumers have grown tired of their harvested data exploitation, and winds of change are blowing in new modalities that cater to security and privacy. Nothing is more representative of the ongoing shift than Apple’s recent operating system changes that feature one of the world’s few welcomed pop-ups: one that asks if it’s okay to track your activity. Welcome to the age of “small and wide” data. Companies are already looking to next-generation technology to meet this new demand, including that of Streamlytics (Profile), which doesn’t use cookies or tracking in its human-led data. The mix of consumer and regulatory blowback has all the majors, including Palantir Technologies Inc. Class A (NYSE: PLTR), Snowflake Inc. Class A (NYSE: SNOW), Oracle Corporation (NYSE: ORCL), Salesforce.com Inc (NYSE: CRM) and Microsoft Corporation (NASDAQ: MSFT) dedicated to advanced functionality to meet or surpass obligations for privacy, governance and compliance associated with collecting and using personal information.

The concept of “big data” has been around for decades but only took on its current form in the 21st century with computers running 24/7/365 processing mounds of user data to better understand and predict trends. However, consumers have grown tired of their harvested data exploitation, and winds of change are blowing in new modalities that cater to security and privacy. Nothing is more representative of the ongoing shift than Apple’s recent operating system changes that feature one of the world’s few welcomed pop-ups: one that asks if it’s okay to track your activity. Welcome to the age of “small and wide” data. Companies are already looking to next-generation technology to meet this new demand, including that of Streamlytics (Profile), which doesn’t use cookies or tracking in its human-led data. The mix of consumer and regulatory blowback has all the majors, including Palantir Technologies Inc. Class A (NYSE: PLTR), Snowflake Inc. Class A (NYSE: SNOW), Oracle Corporation (NYSE: ORCL), Salesforce.com Inc (NYSE: CRM) and Microsoft Corporation (NASDAQ: MSFT) dedicated to advanced functionality to meet or surpass obligations for privacy, governance and compliance associated with collecting and using personal information.

In 2020, Canada became the largest exporter of dried cannabis flower in the world. Today, Canada is looking over its shoulder at a formidable competitor in Colombia, which recently instigated some legislative changes that position the country to become the global cannabis leader. Colombia was already recognized for its robust infrastructure, distribution and exports of certain cannabis products such as medicinal oils and extracts, but the country had a gaping hole in exports by keeping dried cannabis flower strictly verboten. That hole was filled on July 23, 2021, when Colombian President Ivan Duque signed a legislative decree ending the prohibition on the export of dried cannabis flower — a significant global market and a potential windfall for Flora Growth Corp. (NASDAQ: FLGC) (Profile) and its expansive global operations. The broader industry should also benefit from this latest development since most majors, including Canopy Growth Corporation (NASDAQ: CGC), Tilray Inc. (NASDAQ: TLRY), Cronos Group Inc. (NASDAQ: CRON) and Sundial Growers Inc. (NASDAQ: SNDL), support the mainstream worldwide evolution of legal cannabis.

In 2020, Canada became the largest exporter of dried cannabis flower in the world. Today, Canada is looking over its shoulder at a formidable competitor in Colombia, which recently instigated some legislative changes that position the country to become the global cannabis leader. Colombia was already recognized for its robust infrastructure, distribution and exports of certain cannabis products such as medicinal oils and extracts, but the country had a gaping hole in exports by keeping dried cannabis flower strictly verboten. That hole was filled on July 23, 2021, when Colombian President Ivan Duque signed a legislative decree ending the prohibition on the export of dried cannabis flower — a significant global market and a potential windfall for Flora Growth Corp. (NASDAQ: FLGC) (Profile) and its expansive global operations. The broader industry should also benefit from this latest development since most majors, including Canopy Growth Corporation (NASDAQ: CGC), Tilray Inc. (NASDAQ: TLRY), Cronos Group Inc. (NASDAQ: CRON) and Sundial Growers Inc. (NASDAQ: SNDL), support the mainstream worldwide evolution of legal cannabis.

One of the most pervasive diseases in first-world countries, heart disease is the leading cause of death for men and women of most racial and ethnic groups in the United States, with one person dying every 36 seconds from cardiovascular disease. According to the Centers for Disease Control and Prevention (“CDC”), high blood pressure, or hypertension, is a key risk factor for both heart disease and stroke, and nearly half of all adults in the United States, or 108 million, have hypertension — yet only about 24% of those have their condition under control. Many don’t even know they have it. The urgency of finding effective treatments for this life-threatening disease can’t be understated, with many companies, including Lexaria Bioscience Corp. (NASDAQ: LEXX) (Profile), with its patented DehydraTECH(TM) drug delivery, joining the effort to offer safe, effective and affordable treatments. Hypertension and related conditions are also points of focus for other drug-making juggernauts such as Pfizer Inc. (NYSE: PFE), Merck & Company Inc. (NYSE: MRK), Novartis AG (NYSE: NVS) and AstraZeneca PLC (NASDAQ: AZN).

One of the most pervasive diseases in first-world countries, heart disease is the leading cause of death for men and women of most racial and ethnic groups in the United States, with one person dying every 36 seconds from cardiovascular disease. According to the Centers for Disease Control and Prevention (“CDC”), high blood pressure, or hypertension, is a key risk factor for both heart disease and stroke, and nearly half of all adults in the United States, or 108 million, have hypertension — yet only about 24% of those have their condition under control. Many don’t even know they have it. The urgency of finding effective treatments for this life-threatening disease can’t be understated, with many companies, including Lexaria Bioscience Corp. (NASDAQ: LEXX) (Profile), with its patented DehydraTECH(TM) drug delivery, joining the effort to offer safe, effective and affordable treatments. Hypertension and related conditions are also points of focus for other drug-making juggernauts such as Pfizer Inc. (NYSE: PFE), Merck & Company Inc. (NYSE: MRK), Novartis AG (NYSE: NVS) and AstraZeneca PLC (NASDAQ: AZN).